Wan Shan Chen's Securities Sale in Belite Bio, Inc

Wan Shan Chen, an affiliate of Belite Bio, Inc, has filed a notice of securities sale under Rule 144. The filing details the sale of 9,550 common shares of Belite Bio, Inc, with an aggregate market value of $1,164,500. The securities were acquired through non-qualified stock awards on December 29, 2020, and August 26, 2024. The sale is scheduled to occur on October 17, 2025. Additionally, Chen has sold 2,100 common shares in the past three months, with gross proceeds totaling $173,250. The transactions were facilitated by J.P. Morgan Securities LLC.